This technique has some advantages, including reproducibility, cost effectiveness, and fast and precise measurement of the IgG and IgM antibody levels, as well as the ability to perform more clinical tests for other biomarkers, such as C-reactive protein (CRP), which also needs to be monitored in COVID-19 suspects [107,165]. The gene discussed is CD40LG; the disease is COVID-19.